President Felipe Calderón explained that 80 percent of deaths in Mexico are caused by diseases such as diabetes, hepatitis, cancer, cardiovascular disease and multiple sclerosis.
That's why he signed a reform on Tuesday modifying the Regulations for Biotechnological Health Materials to increase the public’s access to innovative medicines.
The President explained that these drugs, unlike traditional ones, are not developed from chemicals but from proteins that come from living animals, which makes their production more costly. “The announcement released is of the utmost importance to the health of the national pharmaceutical industry and the Mexican economy,” the President said. “With this decree, we will build a competitive pharmaceutical industry which will put the most innovative medicines in the hands of Mexicans and the most marginalized people in society.”
The reform at hand will place Mexico in the vanguard of the medical world along with Canada, the United States, and the European Union. “We are embarking on a new medical era in Mexico,” he said.
